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Abstract 
Objectives To determine the sensitivity and specificity of first trimester ultrasound for the detection of fetal 
abnormalities; and to establish which factors might impact this screening.  
Methods 
Systematic review and meta-analysis of all relevant publications assessing the diagnostic accuracy of first 
trimester 2D (transabdominal and transvaginal) ultrasound in the detection of congenital fetal anomalies 
prior to 14 weeks gestation was performed. The reference standard used was the detection of abnormalities 
at birth or postmortem. Factors that may impact detection rates were evaluated including population 
characteristics, gestation, healthcare setting, ultrasound modality, use of an anatomical checklist for first 
trimester anomaly detection and what types of malformations were included in the study. In an effort to 
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reduce the impact of study heterogeneity on results of the meta-analysis, data from the studies were 
analyzed within subgroups of major anomalies versus all types of anomalies; and low risk / unselected 
populations versus high risk populations.  
Results: 
An initial electronic search identified 2,225 citations, from which a total of 30 relevant studies, published 
between 1991 and 2015, were selected for inclusion. For low risk or unselected populations (19 studies, 
115,731 fetuses) the pooled estimate for detection of major abnormalities was 46.10% (95% C.I. 36.88-
55.46). The detection rate for all abnormalities in low risk or unselected populations was 32.35% (95% C.I. 
22.45-43.12), in 14 studies (97,976 fetuses); while the detection rate in high risk populations for the 
presence of all types of anomalies (six studies, 2,841 fetuses) was 61.18% (95% C.I. 37.71-82.19). Of the 
factors examined impacting detection rates there was a statistically significant relationship between the use 
of an anatomical protocol during first trimester anomaly screening and sensitivity for the detection of fetal 
anomalies in all subgroups (P<0.0001).  
Conclusion 
Detection rates for first trimester anomalies range from 32% in low risk, to over 60% in high risk groups. 
This demonstrates that first trimester ultrasound has the potential to identify a large proportion of fetuses 
affected with structural anomalies. The use of a standardized anatomical protocol improves the sensitivity 
of first trimester ultrasound screening for all anomalies and major anomalies in populations of varying risk. 
The development and introduction of international protocols with standard anatomical views should be 
undertaken, in order to optimize rates of first trimester anomaly detection.  
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Introduction 
The main objectives of prenatal ultrasound at 11-13+6 weeks of gestation are confirming 
fetal viability; establishing an accurate gestational age from the measurement of fetal 
crown-rump length (CRL); identifying multiple pregnancies and determining their 
chorionicity and amnionicity; and screening for major fetal anomalies - both structural 
abnormalities and aneuploidies (1). In many settings, screening for chromosomal 
anomalies is undertaken by measurement of fetal nuchal translucency (NT), in 
combination with maternal age; other ultrasound markers (e.g. the fetal nasal bone, 
ductus venosus flow, fetal heart rate and assessment of tricuspid valve flow); and 
measurement of maternal serum free beta hCG and PAPP-A, in the form of a combined 
test. This screening method is associated with high sensitivity and a relatively low false 
positive rate (2-4).  
 
The recent development of cell-free DNA screening using maternal blood is transforming 
our expectations of first trimester aneuploidy detection(5). As this innovative technology 
becomes increasingly accessible and cost-effective, it will complement (and may 
ultimately supersede) current combined screening. Thus, the objectives of the first 
trimester ultrasound scan will need to evolve once again. The many advantages of first 
trimester ultrasound mean it is likely to continue; this should include measurement of 
fetal NT, as increased NT is linked to structural congenital anomalies, notably major 
cardiac defects(6); and may also be indicative of chromosomal aberrations that are not 
detectable with cell-free DNA screening. In addition, first trimester screening for 
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pregnancy complications , such as early pre-eclampsia and very early preterm birth, are 
commonly used as a tool for pregnancy risk stratification(7).  
 
Nevertheless, it is our opinion that the resulting shift in aneuploidy screening, in 
combination with improvements in ultrasound technology, will mean that the role of first 
trimester ultrasound will increasingly be in the visualization of fetal anatomy(8-11). Thus, 
while fetal anomaly screening has traditionally been performed in the second trimester, 
many structural abnormalities can reliably be diagnosed between 11 and 14 weeks(12-14) 
with obvious advantages. However, the varying sensitivity of the test means there is little 
consensus internationally as to whether first trimester anomaly screening is valuable for 
use in daily clinical practice. In addition there is currently a limited understanding of 
which factors impact the success of first trimester anomaly detection, and how this 
screening should be optimally performed.  
 
Within this context, our aim was to perform a systematic review and meta-analysis of 
current literature in order to assess the sensitivity and specificity of first trimester 
anomaly detection; and crucially, to determine which factors might impact this screening 
test.  
 
Methods 
 
Search Strategy 
A systematic electronic search was conducted in order to identify all relevant publications 
assessing the diagnostic accuracy of first trimester two-dimensional ultrasound for the 
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detection of congenital fetal anomalies. The search was conducted using Medline, 
Embase, Web of Science and The Cochrane Library with no publication-year restrictions. 
Free-text terms and medical subject headings related to prenatal screening, early 
pregnancy and congenital anomalies were used (please see Supplement A for full search 
strategy). The electronic search was completed on July 29th, 2015.  
Study selection was performed in multiple stages. Initially, the database of studies 
collected from the electronic search was screened using article titles and abstracts, where 
available. On this basis, a list of potentially suitable articles for inclusion in the 
systematic review was formulated. The full texts of these articles were then assessed in 
order to determine which studies met the inclusion criteria. Reference lists of all eligible 
studies were screened for additional citations, which may not have been identified by the 
initial electronic search. 
 
Study Selection 
All studies, which reported the detection of fetal structural abnormalities using two-
dimensional ultrasound prior to 14 weeks gestation, were included. Prospective 
observational studies, retrospective observational studies and randomized control trials 
were all eligible for inclusion. Literature reviews, abstracts, case reports, editorial letters, 
personal communications and non-English language publications were excluded. Every 
attempt was made to identify incidences where multiple publications from the same 
group shared population subjects. In these cases, only the most recent study from the 
group was included in the review. 
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Studies reporting sensitivity of first trimester anomaly screening in either singleton or 
multiple pregnancies in any healthcare setting and pregnancies of all levels of risk were 
eligible for inclusion. Prospective studies were included based on their intention to 
perform ultrasound screening prior to 14 weeks, with the understanding that the reality of 
clinical practice means that all scans would not necessarily be performed within this time 
period.  
 
This review included studies collecting data on all types of structural abnormalities, 
which included lethal, major, moderate and minor abnormalities as defined by the Royal 
College of Obstetrics & Gynaecology(15). Only those studies which gave an individual 
breakdown of the fetal structural anomalies detected within their population cohort were 
eligible for inclusion. Publications focused on a specific malformation, or specific groups 
of anatomical malformations (e.g. cardiac malformations only) were excluded. Studies 
where the aims were solely to investigate the use of first-trimester ultrasound for the 
detection of fetal chromosomal abnormalities, or soft markers, were also excluded.  
Studies utilizing various modes of two-dimensional ultrasound, including transvaginal 
ultrasound, transabdominal ultrasound and a combination of both, were eligible for 
inclusion. However, studies evaluating fetuses using three-dimensional ultrasound 
modalities were excluded.  
 
The reference standard used to determine the accuracy of first trimester anomaly 
screening was the detection of fetal structural abnormalities at birth or later. As such, 
studies which did not perform a post-natal examination or which did not obtain data 
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regarding neonatal outcome for the purposes of confirming true positive, false positive, 
true negative and false negative results, were excluded. Regarding post-mortem 
examination of all fetuses we took a pragmatic approach: this did not form a requirement 
for inclusion in the review, as it must be accepted that this often not possible following 
first trimester termination of pregnancy. 
 
Data Extraction 
Review of all articles included within this meta-analysis and the reporting of all results 
was conducted based on the Meta-Analysis of Observational Studies in Epidemiology 
(MOOSE) guidelines(16) and the Synthesizing Evidence from Diagnostic Accuracy Tests 
(SEDATE) guidance(17).  
 
For each study, the following data were recorded: name of the author, year of publication, 
sample size; as well as a list of modifiable and non—modifiable factors that may impact 
the detection rates. These were: population characteristics, gestation at which ultrasound 
was performed, type of healthcare setting, the index test used (i.e. ultrasound modality – 
either transvaginal ultrasound, transabdominal ultrasound or both), whether an 
anatomical checklist was used for first trimester anomaly detection, whether a heart 
examination was specifically performed during screening and what types of 
malformations were included in the study. With respect to the use of an anatomical 
checklist for performing the first trimester anomaly scan, studies were graded as either 
having a basic checklist, a detailed checklist or none; studies which did not declare the 
use of an anatomical checklist were declared as having none. A basic checklist was 
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defined as one which requires observation of certain anatomical regions or the presence 
of specific organs. A detailed checklist was defined as one which directs the sonographer 
to visualize multiple specific regions of at least one of the organs listed; and which may 
also include planes of insonation or taking of measurements; or uses advanced ultrasound 
markers such as intracranial translucency or retronasal triangle. For example, a checklist 
which lists ‘head’ would be considered a basic checklist; while one which lists ‘cranial 
ossification, interhemispheric falx, butterfly-shaped choroid plexus’ would be considered 
detailed. 
 
An initial attempt was made to collect data with respect to the level of experience and 
training of sonographers in each study. However, the majority of studies reported no such 
data, and those that did provided data which was not amenable to comparison, so this was 
abandoned.  
 
Finally, a search of all studies was undertaken to determine what modifiable and non-
modifiable factors were specifically cited by study authors as having a significant impact 
on the accuracy and efficiency of first trimester anomaly screening.  
 
When assessing the sensitivity of first trimester anomaly screening, it is possible to define 
this as the number of abnormalities detected; and also as the number of fetuses identified 
with one or more anomaly. Both outcomes are important: the first determines the 
accuracy of first trimester ultrasound in detecting individual anomalies of varying 
severity, whereas the second provides an understanding of how many fetuses are 
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impacted by first trimester anomaly screening. Therefore, the number of abnormalities 
present in each study population and their proportion detected at first trimester screening 
were documented. In addition, the number of fetuses in each study cohort affected with 
one or more structural malformations was noted along with the number of these fetuses 
identified in the first trimester.  
 
Due to the heterogeneity of the studies included in this review, considerable efforts were 
made to ensure that the results of the studies were comparable. Our review was therefore 
required to develop strict definitions for what constitutes ‘one detected structural 
abnormality’. Firstly, it was decided that all bilateral defects such as bilateral renal 
agenesis would be counted as two individual structural anomalies. This was done so that 
our review would be able to distinguish between a fetus with exclusive unilateral renal 
agenesis diagnosed in the first trimester (‘one correctly diagnosed anomaly’) and a fetus, 
diagnosed with unilateral renal agenesis, with a missed bilateral defect (‘one correctly 
identified anomaly, one missed anomaly diagnosis’). This is particularly important 
because it provides the most accurate data for analysis of first trimester screening 
sensitivity. Second, fetuses which were diagnosed with a syndrome (eg. Dandy-Walker 
syndrome) were considered to have one abnormality. The diagnosis of a syndrome is 
often made based on the findings of multiple malformations on ultrasound. However, in 
the majority of studies, there was no specification as to how many constituent anomalies 
were detected in order to make the diagnosis of a specific syndrome and moreover 
whether these anomalies were all detected in the first trimester. As such, the only way to 
unify the analysis of all the studies was to treat the ultrasound diagnosis of one syndrome 
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as one anomaly. Thirdly, in several studies, a single fetus would be attributed to having 
multiple anomalies within one organ system (eg. ‘multiple skeletal abnormalities’). In 
this case, the fetus was considered to have one structural (“a skeletal”) abnormality. 
Finally, single umbilical artery was considered a structural variant of normal anatomy 
and therefore excluded from data collection, as were soft markers for fetal aneuploidy 
(including increased nuchal translucency and absent nasal bone). Of note, cystic 
hygromas were excluded from analysis. The diagnosis of a cystic hygroma is often 
defined as the presence of a bilateral, cystic structure within the occipitocervical region, 
distinguished by the presence of septations within the cystic fluid. However, evidence 
suggests that cystic hygromas should not be considered as a distinct entity from increased 
nuchal translucency(18) and do not confer any ‘risk status’, which is independent of that 
related to increased nuchal translucency(18). As such, within our review, cystic hygromas 
were considered soft markers for aneuploidy, much like increased nuchal translucency, 
and therefore were excluded from our analysis of structural anomalies.  
 
Data regarding the number of false positive diagnoses made during the first trimester 
screening process was also collected. In many studies, women were offered the option of 
anomaly screening in the second and/ or third trimesters of pregnancy in addition to their 
first trimester anomaly scan. In these cases, the number of antenatal diagnoses made 
outside of the first trimester was recorded. All data were collected and extracted from 
tables or text for each study on two independent occasions.  
 
Quality Assessment of Studies 
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Assessment of the quality of studies included within this review was performed using the 
Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2)(19). This is a tool 
designed to evaluate the risk of bias within each study and assess its applicability to the 
systematic review. It provides a framework for evaluating studies within four key 
domains: patient selection, the index test, the reference standard and the flow of patients 
through the study along with the timing of the index test. Each domain is assessed with 
respect to bias, and the first three domains with respect to applicability. A judgment of 
‘low, high or unclear’ risk of bias and lack of applicability was made for each study 
based on a series of signaling questions developed specific to our review (please see 
Supplement B). 
 
Data Analysis 
In an effort to reduce the impact of study heterogeneity on the results of the meta-
analysis, data from the studies was analyzed within subgroups, which reflected the types 
of abnormalities included and the type of population assessed by each study. Extracted 
data was assessed within one of three subgroups:  
(1) Studies reporting on major anomalies in a low risk or unselected population,  
(2) Studies assessing all types of anomalies in a low risk or unselected population and  
(3) Studies examining all types of anomalies in high risk populations.  
When studies published adequate data on two distinct cohorts, then the relevant data from 
each study was included within more than one subgroup. In studies performed in 
unselected populations, where anomaly type was defined using RCOG criteria, anomalies 
labeled as lethal or severe were considered ‘major anomalies’ and therefore analyzed as 
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part of subgroup 1 whereas anomalies labeled as ‘lethal, severe, moderate or minor’ were 
included as part of subgroup 2. In studies not based on RCOG criteria, the definition 
provided by the study itself was used to determine what constituted a major anomaly.  
Meta-analysis of data extracted from eligible studies was performed in two steps. First, 
summary statistics with 95% C.I. were derived for each study with respect to both the 
sensitivity of first trimester anomaly screening for detecting fetal anomalies and for 
detecting fetuses affected by one or more abnormality. Second, individual study statistics 
within each subgroup were combined in order to obtain a pooled summary estimate. In 
those studies providing adequate data for the construction of 2x2 tables, pooled summary 
estimates of sensitivity and specificity were calculated. The pooled summary statistics 
were estimated using random effects models(17). Heterogeneity between studies was 
estimated using I2. Further analysis was undertaken within each subgroup in order to 
determine whether factors such as year of study publication, mode of ultrasound and the 
use of an anatomical protocol impacted outcomes. 
  
All statistical analysis was performed using StatsDirect statistical software (England, 
2013).  
 
Results 
 
Study Selection and Description of Included Studies 
 
The initial electronic search yielded 2,225 citations, from which a total of 30 relevant 
studies were selected for inclusion in the systematic review (Figure 1). The studies 
evaluated were published between 1991 and 2015. The gestational age at which scans 
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were performed ranged from 9 to 15+6 weeks gestation, with the vast majority completed 
prior to fourteen weeks. Studies were performed in a variety of healthcare settings with 
the majority taking place, at least in part, in either a University Hospital, Tertiary Care 
Centre or Research Facility (n=20 studies). Three studies involved multi-centre data 
collection. 
 
Several studies in the review included adequate data on several distinct cohorts, allowing 
for data from these studies to be analyzed as part of multiple subgroups (see Supplement 
C). 
In total, there were 26 studies evaluating unselected and low risk populations (Table 1) of 
which  
- 19 study cohorts focused on the detection of major anomalies (n =115,731 
fetuses)  
- 14 study cohorts assessed all types of anomalies (n=97,976 fetuses).   
There were 6 studies which focused on detecting all types of anomalies in high-risk 
populations representing a total of 2,841 fetuses (Table 2).  
 
Subgroup 1 – Sensitivity of first trimester anomaly screening for the detection of 
major anomalies in a low risk/unselected population 
 
There were nineteen study cohorts (n =115,731 fetuses) which evaluated a low risk or 
unselected population for the presence of major anomalies (Table 3). There were 1165 
anomalies (mean number of major structural abnormalities present per 100 fetuses = 1.01, 
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95% C.I. 0.95-1.07). Of these, 529 were detected during the first trimester giving a 
sensitivity of first trimester ultrasound for the detection of major fetal abnormalities 
(pooled estimate) of 46.10% (95% C.I. 36.88-55.46, Figure 2(i). Heterogeneity as 
estimated by I2 was 90.1% (95% C.I. 86.5-92.4%)  
 
In fifteen of these study cohorts (n= 77,664 fetuses), an additional ultrasound after the 
first trimester of pregnancy was performed. In these studies, the abnormalities detected in 
the first trimester represented 53.47% (95% C.I. 43.42-63.37) of all antenatal ultrasound 
anomaly diagnoses.  
 
Twelve of these study cohorts (n= 61,930 fetuses) provided data on the number of fetuses 
affected with one or more structural abnormalities: 573 were affected with structural 
anomalies, of which 264 were detected during the first trimester. The mean prevalence of 
affected fetuses was 0.93% (95% C.I. 0.85-1.00). The mean sensitivity of first trimester 
ultrasound for the detection of fetuses affected by one or more anomalies (pooled 
estimate – Figure 2(ii) was 45.25% (95% C. I. 38.44-52.14). It was possible to create 
complete 2x2 tables for the three studies providing false positive rates (pooled sensitivity 
– 41.98% [95% C.I. 23.83-61.33], pooled specificity – 99.96% [95% C.I. 99.90-100.00]). 
 
Subgroup 2 – Sensitivity of first trimester anomaly screening for the detection of all 
types of anomalies in a low risk/unselected population 
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There were fourteen study cohorts (n=97,976 fetuses), which evaluated a low risk or 
unselected population for the presence of all types anomalies (Table 4). Thirteen of these 
study cohorts (n= 84,253 fetuses) reported 1,521 anomalies (mean number per 100 
fetuses = 1.81, 95% C.I. 1.72-1.90). Of these, 526 were detected during the first trimester 
giving a pooled sensitivity of first trimester ultrasound for the detection of fetal 
abnormalities of 32.35% (95% C.I. 22.45-43.12, Figure 3(i)). Heterogeneity as estimated 
by I2 was 93.5% (95% C.I. 91.1-95.0%).  
 
In twelve study cohorts (n=77,561 fetuses) reporting on the detection of individual 
anomalies, antenatal ultrasound was performed on an additional occasion after the first 
trimester of pregnancy. In these studies, the abnormalities detected in the first trimester 
represented 41.10% (95% C.I. 32.13-50.38) of all antenatal ultrasound anomaly 
diagnoses.  
 
Nine studies (n= 77,186 fetuses) provided data on the number of fetuses affected with 
one or more structural abnormalities (Table 4): 1256 were affected with structural 
anomalies (prevalence 1.63%, 1.54-1.72). Of these, 435 were detected during the first 
trimester (pooled estimated sensitivity 35.56%, 26.27-45.44, Figure 3(ii)). It was possible 
to create complete 2x2 tables for the three studies providing false positive rates (pooled 
sensitivity – 44.44% [95% C.I. 32.76-56.44], pooled specificity – 99.86% [95% C.I. 
99.82-99.89]) 
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Subgroup 3 – Studies assessing the sensitivity of first trimester anomaly screening 
for the detection of all types of anomalies in a high risk population 
There were six studies, which evaluated a high risk population for the presence of all 
types anomalies (Table 5). Within these studies (n=2,841 fetuses), there were 186 
anomalies present, of which 116 were detected during the first trimester. The mean 
number of major structural abnormalities present per 100 fetuses was 6.55 (95% C.I. 
5.66-7.52), confirming the high risk status of this population. The mean sensitivity of first 
trimester ultrasound for the detection of all types of fetal abnormalities (pooled estimate - 
Figure 4(i) was 61.18% (95% C.I. 37.71-82.19). Heterogeneity as estimated by I2 was 
90.5% (95% C.I. 82.1-94.0%)  
 
Abnormalities detected in the first trimester represented 66.29% (95% C.I. 43.47-85.69) 
of all antenatal ultrasound anomaly diagnoses.  
 
Five studies (2,345 fetuses) provided data on the number of fetuses affected with one or 
more structural abnormalities within their population cohort. Based on the 2,345 fetuses 
reported in these five studies, 88 were affected with structural anomalies, of which 48 
were detected during the first trimester. The mean prevalence of affected fetuses was 
3.75% (95% C.I.: 3.02-4.60). The mean sensitivity of first trimester ultrasound for the 
detection of fetuses affected by one or more anomalies (pooled estimate – Figure 4(ii) 
was 62.42% (95% C.I: 33.40-87.24). Complete 2x2 tables for the three studies providing 
false positive rates were compiled (pooled sensitivity – 79.85% [95% C.I. 43.87-99.29], 
pooled specificity – 97.78% [95% C.I. 90.96-100.00])  
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Factors Impacting Detection Rates in First Trimester Anomaly Screening 
A chi-squared test demonstrated a statistically significant relationship between the use of 
an anatomical protocol during first trimester anomaly screening and sensitivity for the 
detection of fetal anomalies in all subgroups (subgroup 1: chi-squared 60.95, P<0.0001, 
subgroup 2: chi-squared 112.46, P<0.0001, subgroup 3: chi-squared 24.71, P<0.0001).  
 
In subgroups 1 and 2 there was a statistically significant chi-squared for linear trend 
(P<0.0001) suggesting that use of an increasingly detailed protocol resulted in higher 
sensitivity for the detection of fetal anomalies.  
 
Simple linear regression analysis showed no statistically significant relationship between 
the year of publication study and sensitivity for anomaly detection in either of subgroup 1 
(R2 = 0.066), subgroup 2 (R2 = 0.030) or subgroup 3 (R2 = 0.44). 
  
The impact of the mode of ultrasound used for screening on detection rates was also 
explored. The vast majority of studies used a combination of TA and TV ultrasound, 
often beginning with the former and then complementing with the latter when organ 
visualization was suboptimal. In all three subgroups, there were insufficient studies using 
TA or TV ultrasound exclusively in order to make useful comparisons between detection 
rates using one of the three methods (TA, TV or combination of both). 
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Finally, with respect to the collection of qualitative data, studies evaluated as part of this 
systematic review cited numerous factors as having an impact on first trimester detection 
rates for fetal anomalies. Non-modifiable factors cited included: the small size of fetal 
anatomy at this gestational age(20-26), the progressive patho-physiology of certain fetal 
anomalies and the fact that some anomalies are not yet present in the first trimester(14, 21, 
22, 24-32),  raised maternal BMI(24, 33) and the presence of uterine fibroids(27, 33). A number 
of modifiable factors were considered to impact first trimester anomaly screening 
including: gestational age at time of scan(24), mode of ultrasound use(20, 24, 29, 34, 35), time 
allocated for screening(14, 20, 24, 25, 30, 33), use of an anatomical protocol with standard 
sonographic views(14, 20, 27, 35-37), sonographer experience and training(14, 20, 23-25, 27, 29, 30, 33, 
35-42), system in place for regular audit(30, 35, 36), knowledge of fetal embryology including 
normal developmental milestones in the first trimester(21, 25, 26, 31) and knowledge of easily 
recognizable markers for the diagnosis of anomalies such as spina bifida and facial 
clefts(14).  
 
Methodological Quality Assessment of Studies 
Results of the QUADAS-2 assessment are summarized in Figure 5. With respect to bias 
in patient selection, eighteen of thirty studies were scored low risk for bias. Two studies 
were deemed at high risk of bias due to inappropriate exclusions from their patient 
cohorts. Nine studies were labeled ‘unclear’ with respect to bias due to lack of 
information provided on the methods used to enroll patients. In four studies, there was no 
information pertaining to patient exclusions and therefore they were also labeled unclear. 
With respect to the index test, none of the studies declared whether their sonographers 
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were blinded to the history of patients prior to performing anomaly screening, and 
therefore all studies were labeled as unclear in this regard. Five studies excluded cardiac 
examinations from their first trimester anomaly screening and were therefore considered 
at high risk of bias. Four additional studies provided no specification as to the types of 
anomalies included in their assessment and as such were labeled as high risk. All thirty 
studies were found to be low risk for bias relating to the reference standard; this was after 
all a criterion for inclusion in this study. In terms of flow and timing, fifteen out of thirty 
studies were labeled as high risk for bias because they included no data pertaining to false 
positive diagnoses. One further study was labeled as high risk because a reference 
standard was performed in less than 90% of the patients enrolled in the study. With 
respect to applicability, there were no concerns raised regarding the thirty studies 
included in this review.  
 
Discussion 
In this study we show that first trimester ultrasound can identify about half of all major 
anomalies diagnosed antenatally (Table 6): in unselected and low risk pregnancies about 
40% of all antenatally diagnosed anomalies can be identified at this stage. The detection 
rates for major anomalies are higher (46%) with 45% of fetuses affected with one or 
more major malformations identified. Finally, in high risk populations, sensitivity for 
anomaly detection was even higher (61%), with first trimester screening detecting 66% of 
all antenatal ultrasound diagnoses. This higher rate of detection in high risk populations is 
likely due to targeted screening (13): sonologists are aware of the increased risk; and 
women at high risk may be scanned by more expert examiners. Nevertheless, 
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theoretically at least, the detection rate of an anomaly should not be influenced by its 
prevalence in the population cohort.  
 
This suggests that first trimester ultrasound has the potential to identify a high percentage 
of fetuses affected with structural anomalies in all risk groups: if we have the technology 
and skill available to achieve sensitivities of over 60% in high risk populations, there is 
no reason that under optimal conditions these detection rates could not be achievable for 
all patients. This idea of “if you look you will find” is further supported by an important 
result from our analysis of all three subgroups: a significant association (P<0.001) 
between the sensitivity of first trimester ultrasound and the use of an anatomical protocol 
for screening; and a trend suggesting that the more detailed the protocol used, the greater 
the detection rates.  We therefore suggest that international protocols with standard 
anatomical views should be used in practice, in order to optimize rates of first trimester 
anomaly detection.  
 
Most studies used a combination of TV and TA ultrasound, which meant that a 
statistically useful comparison between sensitivities from studies using one of the three 
methods (TA, TV or combination of both) could not be performed. Findings from studies 
evaluating fetal organ detection suggest that optimal visualization rates are obtained with 
a combination of TA and TV ultrasound (8). For TA, raised BMI, fibroids or retroversion 
of the uterus will decrease image quality. In contrast, TV ultrasound provides much 
higher resolution, but has the disadvantage of limited probe maneuverability(43); some 
women may also find TV ultrasound to be a less acceptable test. (34, 44). We believe that 
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adopting a flexible, patient tailored approach, which may require use of TA and TV 
modalities, should be encouraged as this will be the only way of determining the true 
potential of first trimester anomaly detection.  
 
A number of other factors affecting first trimester ultrasound were suggested by authors. 
These provide insights into how the process might be optimized: several studies 
demonstrate a significant “learning curve” associated with first trimester anomaly 
screening; (38, 45) (30) knowledge of fetal embryological development is also important (46); 
as is the time allocated for screening. Apart from using an anatomical protocol, Syngelaki 
et al.(14) highlights the positive impact of having an easily recognizable marker for the 
diagnosis of anomalies, such as spina bifida or facial clefts, on overall detection rates.  
 
Non-modifiable factors impacting detection rates include the small size of anomalies and 
fetal crown rump length; and the presence of anomalies with progressive 
pathophysiology. Studies assessing the types of anomalies detected (14) (13) suggest that 
there are some conditions which are nearly always detectable in the first trimester; others 
that are never identifiable; and some that may potentially be diagnosed, depending on 
maternal, fetal, sonographer and equipment factors. Undetectable anomalies mostly relate 
to structures not yet fully developed prior to 14 weeks, e.g. cerebellar anomalies and 
echogenic lung cysts; or those diagnosed secondary to changes in amniotic fluid, e.g. 
duodenal atresia, bowel obstruction or renal agenesis. Thus, first trimester anomaly 
screening will never replace that at later gestations completely. What is clear from our 
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rti
cl
e
assessment is that expectations and future objectives for first trimester anomaly screening 
must be tailored to the types of anomalies amenable to detection at this gestation. 
 
Limitations of this review include the fact that, despite subgroup analysis, there remained 
considerable heterogeneity between studies: extensive variation between the studies 
existed in inclusion and exclusion criteria; the age at postnatal follow; use of anatomical 
protocols used; and outcome reporting. The types of anomalies examined was different, 
even amongst those aiming to assess solely ‘major anomalies’. We would therefore 
recommend the use of international definitions, such as the RCOG, EUROCAT or March 
of Dimes criteria in future studies. 
 
A number of studies excluded cardiac anomalies from their analysis, presumably because 
these anomalies are often difficult to diagnose in the first trimester and require significant 
sonographer skill/. The latest BINOCAR data(47) suggest overall antenatal detection rates 
are low (53.1%, 95% C.I. 49.1-57.1) and this must be seen in the context of them being 
common anomalies (82.2 per 10,000 fetuses, 95% C.I. 81.30-83.03)(48). It is impossible to 
develop a proper understanding of the overall impact of first trimester screening on 
antenatal care, or to compare first trimester and second trimester anomaly screening, if 
studies do not include anomalies belonging to all organ systems within their analysis.   
 
Some studies only reported the number of anomalies within their cohort, providing no 
data with respect to the number of affected fetuses. This limits the ability to understand 
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fully the number of fetuses impacted on by first trimester screening initiatives; such 
information must form a minimum standard to be reported.  
 
Finally, it must be highlighted that the majority of studies did not include false positive 
rates. One of the inevitable consequences of first trimester screening is the offer of early 
termination of pregnancy when major anomalies are seen. There is a self-evident concern 
regarding termination after first trimester anomaly screening without a full understanding 
of a false positive diagnosis; however, the rate of false positives is thought to be much 
lower than second trimester screening(38, 45). It is also not that easy to work out what a 
false positive is, as anomalies evolve: for example, a significant proportion of megacystis 
(in particular those ≤15mm) spontaneously resolve later in pregnancy(49). In the study by 
Syngelaki et al. (14), a large proportion of false positive diagnoses involved either 
megacystis or bowel-only exomphalos. As such, it is critical to not only understand the 
rate of false positive diagnoses in first trimester screening, but also what types of 
anomalies are most likely to spontaneously resolve.  
 
Based on recommendations from QUADAS-2(19), the design of a perfect evaluation of 
first trimester anomaly screening would involve blinding of sonographers to patient 
histories; prevention of referral bias in tertiary centre trials; post-mortem analysis of 
every terminated case; standardized neonatal assessment of internal anomalies with 
neonatal echocardiography in all fetuses and blinding of neonatal assessors to the prenatal 
sonography results. Such a rigorous examination of first trimester anomaly screening is 
unlikely to ever be performed on a large scale or in fact to be considered ethical. A 
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historical assessment of second trimester anomaly screening reveals that at the time, there 
were also concerns that it was not adequately evaluated prior to widespread adoption in 
prenatal care, particularly with respect to the burden of false positive diagnoses, optimal 
timing for screening, cost-benefit analysis and the potential for increasing parental 
anxiety(50, 51); and little consensus or uniformity as to how screening should be 
performed(52). However, the process of standardized anatomy protocols, a systematic 
approach to training of sonographers and an emphasis on quality assessment has allowed 
the 20 week scan to become a fundamental component of prenatal care; this is now also 
happening with first trimester ultrasound.  
 
Conclusions 
This systematic review has used subgroup analysis, strict ‘anomaly’ criteria and manual 
extraction of data to obtain the most accurate picture possible of the true sensitivity of 
first trimester anomaly screening. Our findings demonstrate that first trimester ultrasound 
should be considered as a valuable clinical addition to prenatal anomaly screening in low 
risk, high risk and unselected populations. We have demonstrated that the currently 
presented literature represents only the beginning of what is achievable for first trimester 
anomaly screening. It is clear that greater sensitivities can be achieved with the use of a 
detailed anatomical protocol, increased attention to sonographer training and an 
appreciation of the learning curve involved in acquiring these skills.   
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Legends of figures included in the paper: 
Figure 1 – Flowchart demonstrating the search strategy and selection of studies to 
be included in the systematic review and meta-analysis. 
 
Figure 2 – Forest plots demonstrating sensitivity of first trimester ultrasound in low risk 
and unselected pregnancies (i). For the detection of major fetal anomalies. (ii). For the 
detection of fetuses affected with major anomalies. 
 
Figure 3 – Forest plots demonstrating sensitivity of first trimester ultrasound in low risk 
and unselected pregnancies (i). For the detection of all types of fetal anomalies. (ii). For 
the detection of fetuses affected with all types of anomalies.  
 
Figure 4 – Forest plots demonstrating sensitivity of first trimester ultrasound in high risk 
pregnancies (i). For the detection of all fetal anomalies. (ii). For the detection of fetuses 
affected with all types of anomalies. 
 
Figure 5 – Results from QUADAS-2 Quality Assessment of Studies. (i). Proportion of 
studies with low, high, or unclear risk of bias. (ii). Proportion of studies with low, 
high or unclear concerns regarding applicability.  
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Tables 
 
Table 1 – Characteristics of studies reporting on the detection of structural anomalies in low risk and unselected populations 
using first trimester ultrasound. 
Notes:  
(i). In studies where both TA and TV ultrasound were used, the number in parentheses adjacent to the ultrasound modality refers to the 
percentage of the study population which received this screening test (when available).  
(ii). In studies where aneuploid fetuses were included, the percentage of the study population confirmed by karyotyping as aneuploid 
was indicated in parentheses (where available).  
(iii). The subgroup analysis column identifies the group(s) in which the respective study’s data was analyzed.  
* Highlights studies where TV ultrasound was only performed in situations where visualization with TA ultrasound was deemed 
suboptimal.  
**Cardiac exam performed at time of first trimester scan, but cardiac malformations excluded from study analysis. 
***For the purposes of this review, only the cohort of known euploid fetuses was included in analysis (as insufficient data was 
provided on the entire cohort reported in the study). 
 
Group Year 
 
N 
 
Gestation 
(weeks) Population 
Health-
Care 
Setting 
Aneuploid 
Included? Index Test 
Anatomy 
Checklist 
Cardiac 
Exam 
Done? 
Subgroup 
for data 
Analysis 
Achiron(62) 1991 800 9-13 
Mixed 
indications: 
vaginal 
bleeding, 
dating and 
early anomaly 
screening 
Unclear Yes TV/TA Basic Yes 2 
Hernadi(37) 1997 3991 11-14 Unselected Unclear Yes (0.2%) TV Basic No 1 
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Bilardo(25) 
(Low risk) 
 
1998 1543 10-14 
Consecutive, 
Singleton 
pregnancies, 
Normal NT 
(<3.0mm), 
University 
Hospital No TA/TV None Unclear 2 
Whitlow(32) 1999 6443 11-14+6 
Unselected, 
consecutive 
recruitment 
University 
Hospital Yes (0.7%) 
TA/ 
TV(20.1%) Detailed Yes 1 
Carvalho(44) 2002 2853 11-14 Unselected 
University 
Hospital, 
tertiary 
care 
Yes (0.9%) TA/TV* Basic No** 2 
Drysdale(43) 2002 917 12-14 Unselected 
District 
General 
Hospital 
Yes TA/TV None No 1 
Taipale(34) 2003 20,751 11-15+6 
Unselected, 
consecutive 
recruitment 
Local 
hospital Yes (0.3%) 
TV/ 
TA(<1%) Detailed Yes** 1 
 
 
McAuliffe 
(46) 
 
2005 325 11-13+6 Unselected 
University 
Hospital, 
tertiary 
care 
No TA/TV (24.6%)* Detailed Yes 2 
Cedergren 
(39) 2006 2708 11-14 
Unselected, 
consecutive 
recruitment 
University 
Hospital Yes (0.3%) TA None Unclear 1 
Souka 
(30) 2006 1148 11-14 Unselected Unclear Yes TA/TV Detailed Yes 1 
Saltvedt(24) 2006 18053 11+5-13+5 Unselected Multi-centre (8) No TA/TV* Detailed Yes 1 
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Dane(29) 2007 1290 11-14 Unselected Research hospital Yes TA/TV Basic No 1 
Li(28) 2008 2232 11-14 
Unselected, 
consecutive 
recruitment 
Unclear Yes TA/ TV (2.0%)* None Unclear 1 
Chen(19) 
(Control 
group) 
2008 3693 10-14+6 
Unselected, 
consecutively 
randomized, 
Multi-
centre 
(one 
university 
& one 
regional 
hospital) 
Yes TA/TV* None No 1,2 
Chen(19)  
(Study 
group) 
2008 3949 12-14+6 
Unselected, 
consecutively 
randomized 
Multi-
centre 
(One 
university 
& one 
regional 
hospital) 
Yes TA/TV* Detailed Yes 1,2 
Oztekin(42) 2009 1085 11-14 Unselected Research hospital Yes TA/TV* Detailed Yes 1 
Hildebrand 
(21) 2010 6692 11-15 
Unselected, 
consecutive 
recruitment 
University 
Hospital Yes (0.2%) TA None No 1,2 
Abu-
Rustum(38) 2010 1370 11-13
+6 Unselected, retrospective 
Private 
Practice Yes (4.4%) TA/TV* Detailed Yes 1,2 
Syngelaki 
(14) 2011 44,859 11-13
+6 Unselected, Retrospective 
University 
Hospital, 
tertiary 
care 
N TA/ TV(1%) Detailed Y 2 
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Jakobsen(22) 2011 9324 11-15 Unselected, Retrospective 
University 
Hospital Yes TA/TV* None No 1,2 
Vavilala(63) 2011 7916 11-13+6 Unselected Tertiary Care Yes TA/TV* Detailed Yes 1 
Grande(23)  2012 13723 11-14 Unselected retrospective 
Tertiary 
Care No TA/TV Detailed Yes 1,2 
Pilalis(27) 2012 3902 11-14 Unselected, retrospective 
Private 
maternity 
hospital 
Yes TA/TV Detailed No 1 
Becker(64) 2012 6544 11-13+6 Normal NT (≤ 95th centile) 
University 
Hospital 
Yes 
(0.6%)*** 
TA/ 
TV* 
(23.4%) 
Detailed Yes 1 
Iliescu(41) 2013 5472 12-13+6 Unselected Multi-centre (2) Yes (0.4%) 
TA/ 
TV(7.8%) Detailed Yes 2 
Wang(33) 2013 2822 11-14 Not stated University Hospital Yes TA Detailed Yes 2 
Natu(26) 
(Low Risk) 2014 551 11-14wks 
Low risk: 
age<30, no 
FH, no co-
morbidity 
Unclear Yes Unclear Detailed Yes 2 
 
n – Number of fetuses included in the study population. TA – Transabdominal Ultrasound. TV – Transvaginal Ultrasound. FH – 
Family history. NT – Nuchal Translucency. 
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Table 2 – Characteristics of studies reporting on the detection of all types of fetal structural abnormalities using first trimester 
ultrasound in high risk pregnancies.  
 
Group Year 
 
N 
 
Gestation 
(weeks) Population 
Health-
Care 
Setting 
Aneuploid 
Included? 
Index 
Test 
Anatomy 
Checklist 
Cardiac 
Exam 
Done? 
Types of 
Anomalies 
Included 
Pandya(65) 1995 565 10-14 
Euploid fetuses 
with raised NT 
(≥3.0mm) 
University 
Hospital, 
tertiary care 
No TA None No  
Not 
specified 
Bilardo(25) 
(High risk) 1998 47 10-14 
Euploid fetuses 
with raised NT 
(≥3.0mm) 
University 
Hospital No TA/TV None Unclear 
Not 
specified 
Den 
Hollander 
(35) 
2002 101 11-14 
Women with 
previously affected 
infants (92%), 
fetuses with 
parental 
consanguinity 
Tertiary 
care Yes TA/TV Detailed Yes 
Not 
specified 
Chen(31) 2004 1609 12-14wks Women aged ≥35 years 
University 
Hospital Yes TA/TV Detailed Yes 
Not 
specified 
Bronshtein 
(45) 2008 23 11-14wks 
Fetuses with raised 
NT (≥3.5mm) Unclear Yes TV 
Used, but 
not 
provided 
Yes All anomalies 
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Natu(26) 
(High 
Risk) 
2014 496 11-14wks 
Mixed indications 
including age >30, 
prev. affected 
child, FHx of 
anomalies, multiple 
pregnancy, hx of 
smoking/ETOH, 
maternal RF. 
Unclear Yes Unclear Detailed Yes All anomalies 
 
n - Number of fetuses included in the study population. NT – Nuchal Translucency. TA – Transabdominal Ultrasound. TV – 
Transvaginal Ultrasound. 
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Table 3 – Summary of results from studies assessing the sensitivity of first trimester ultrasound for the detection of major fetal 
structural abnormalities in low risk/unselected pregnancies (Subgroup 1)  
 
Group  
 
Number of 
Anomalies 
Present 
Within 
Study per 
100 fetuses  
[95% C.I.] 
 
 
Prevalence of 
Affected 
Fetuses 
within Study 
Population* 
(%)  
[95% C.I.] 
Anomalies 
Detected 
in 1st 
Trimester 
(TP) 
Total 
Anomalies 
Present in 
Study 
(TP+FN) 
False 
Positives 
Detected 
during 1st 
Trimester 
USS 
(FP) 
Sensitivity of 1st 
Trimester USS 
for Anomaly 
Detection (%) 
[95% C.I.] 
Sensitivity of 1st 
Trimester USS 
for Detection of 
Affected Fetuses* 
(%) [95% C.I.] 
 
 
Antenatal 
Diagnoses Made 
Within 1st 
Trimester**  
(%) 
 
Hernadi  1.30 [0.97-1.71] 
1.08 
[0.78-1.45] 20 52 NA 
38.46 
[25.30-52.98] 
32.56 
[19.08-48.54] 
48.78 
[32.88-64.87] 
Whitlow 1.20 [0.94-1.49] 
0.85 
[0.64-1.11] 38 77 3 
49.35 
[37.76-61.00] 
52.73 
[38.80-66.35] 
57.58 
[44.79-69.66] 
Drysdale  4.14 [2.95-5.64] 
2.94 
[1.95-4.26] 5 38 1 
13.16 
[4.41-28.09] 
18.52 
[6.30-38.08] 
11.76 
[3.30-27.45] 
Taipale 0.34 [0.27-0.43] 
0.32 
[0.25-0.41] 37 71 2 
52.11 
[39.92-64.12] 
52.24 
[39.67-64.60] NA 
Cedergren  1.11 [0.75-1.58] 
1.07 
[0.72-1.53] 11 30 NA 
36.67 
[19.93-56.14] 
34.48 
[17.94-54.33] NA 
Souka  1.30]1 [0.73-2.15] 
1.22 
[0.67-2.04] 7 15 3 
46.67 
[21.27-73.41] 
50.00 
[23.04-76.96] 
50.00 
[23.04-76.96] 
Saltvedt  0.74 [0.62-0.87] NA 42 133 2 
31.58 
[23.80-40.20] NA 
34.43 
[26.06-43.57] 
Dane 2.71 [1.90-3.75] 
1.71 
[1.07-2.57] 23 35 NA 
65.71 
[47.79-80.87] 
68.18 
[45.13-86.14] 
71.88 
[53.25-86.25] 
Li  1.16 [0.76-1.70] 
0.99 
[0.62-1.49] 13 26 NA 
50.00 
[29.93-70.07] 
54.55 
[32.21-75.61] 
65.00 
[40.78-84.61] 
Chen  1.19 0.73 9 44 NA 20.45 29.63 20.45 
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(Control 
group) 
[0.87-1.60] [0.48-1.06] [9.80-35.30] [13.75-50.18] [9.80-35.3] 
Chen  
(Study group) 
1.75 
[1.36-2.21] 
1.44 
[1.10-1.87] 41 69 NA 
59.42 
[46.92-71.09] 
43.86 
[30.74-57.64] 
61.19  
[48.50-72.86] 
 
Oztekin 1.81 [1.11-2.78] 
1.75 
[1.06-2.72] 13 20 NA 
65.00 
[40.78-84.61] 
63.16 
[38.36-83.71] 
72.22 
[46.52-90.31] 
Hildebrand  0.49 [0.34-0.69] NA 13 33 NA 
39.39 
[22.91-57.86] NA NA 
Abu-Rustum  1.17 [0.67-1.89] NA 10 16 1 
62.50 
[35.43-84.80] NA 
66.67 
[38.38-88.18] 
Jakobsen  1.07 [0.87-1.30] NA 16 100 NA 
16.00 
[9.43-24.68] NA 
33.33 
[20.40-48.41] 
Vavilala  0.99 [0.78-1.23] NA 69 78 NA 
88.46 
[79.22-94.59] NA NA 
Grande  1.39 [1.20-1.60] 
1.39 
[1.20-1.60] 92 191 NA 
48.17 
[40.90-55.50] 
48.17 
[40.90-55.50] 
51.11 
[43.57-58.62] 
Pilalis 1.54 [1.18-1.97] NA 26 60 NA 
43.33 
[30.59-56.76] NA 
44.07 
[31.16-57.60] 
Becker  1.18 [0.93-1.47] NA 44 77 NA 
57.14 
[45.35-68.37] NA 
64.71 
[52.17-75.92] 
Total Included 1.01 [0.95-1.07] 
0.93 
[0.85-1.00] 
 
529 
 
1165 12 46.10 [36.88-55.46] 
45.25 
[38.44-52.14] 
53.47 
[43.42-63.37] 
 
TP – True positives. FP – False Positives, FN – False Negatives. USS – Ultrasound. NA – Not available. 
*Those studies which did not provide data on the number of affected fetuses within their cohorts were not included in the pooled 
estimates of  ‘Prevalence of affected fetuses’ and of ‘Sensitivity of 1st trimester USS for detection of affected fetuses’. 
**Those studies which only performed one antenatal USS on fetuses during pregnancy were not included in the pooled estimate of 
‘Antenatal anomalies diagnosed during the 1st trimester’. 
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Note: The specificity of first trimester ultrasound for major anomaly detection was not calculated due to the small numbers of 
studies, which provided data on false positive diagnoses. 
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Table 4 – Summary of results from studies assessing the sensitivity of first trimester ultrasound for the detection of all types of 
fetal structural abnormalities in a low risk/unselected pregnancies (Subgroup 2). 
 
Group  
 
Number of 
Anomalies 
Present 
Within 
Study per 
100 fetuses  
[95% C.I.] 
 
 
Prevalence of 
Affected 
Fetuses 
within Study 
Population* 
(%)  
[95% C.I.] 
Anomalies 
Detected in 
1st 
Trimester 
(TP) 
Total 
Anomalies 
Present in 
Study 
(TP+FN) 
False 
Positives 
Detected 
during 1st 
Trimester 
USS 
(FP) 
Sensitivity of 1st 
Trimester USS 
for Anomaly 
Detection (%) 
[95% C.I.] 
Sensitivity of 1st 
Trimester USS 
for Detection of 
Affected Fetuses* 
(%) [95% C.I.] 
 
 
Antenatal 
Diagnoses Made 
with 1st Trimester 
USS** 
(%) 
 
Achiron 2.12 [1.24-3.38] 
1.50 
[0.78-2.61] 8 17 NA 
47.06 
[22.98-72.19] 
50.00 
[21.09-78.91] 
53.33 
[26.59-78.73] 
Bilardo  
(Low risk) 
1.56 
[1.00-2.31] 
1.23 
[0.74-1.92] 6 24 NA 
25.00 
[9.77-46.71] 
31.58 
[12.58-56.55] 
37.50 
[15.20-64.57] 
Carvalho 4.98 [4.21-5.84] NA 30 142 NA 
21.13 
[14.73-28.77] NA 
29.13 
[20.59-38.90] 
McAuliffe 1.85 [0.68-3.97] 
1.85 
[0.68-3.97] 1 6 1 
16.67 
[0.42-64.12] 
16.67 
[0.42-64.12] 
20.00 
[0.51-71.64] 
Chen 
(Control) 
2.11 
[1.67-2.63] 
1.41 
[1.05-1.84] 9 78 NA 
11.54  
[5.41-20.78] 
15.38 
[6.88-28.08] 
16.36 
[7.77-28.80] 
Chen (Study) 2.30 [1.86-2.82] 
1.44 
[1.10-1.87] 44 91 NA 
48.35 
[37.74-59.07] 
43.86 
[30.74-57.64] 
61.97 
[49.67-73.24] 
Abu-Rustum 2.41 [1.66-3.37] NA 12 33 1 
36.36 
[20.40-54.87] NA 
37.50 
[21.10-56.31] 
Hildebrand  1.79 [1.49-2.14] NA 14 120 NA 
11.67 
[6.53-18.80] NA NA 
Syngelaki 1.18 [1.09-1.29] 
1.09 
[0.99-1.19] 222 531 62 
41.81 
[37.57-46.13] 
43.65 
[39.19-48.18] 
42.86 
[38.55-47.25] 
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Jakobsen 
(All) 
1.92 
[1.65-2.22] NA 23 179 NA 
12.85 
[8.32-18.65] NA 
21.90 
[14.42-31.03] 
Grande (All) NA 3.18 [2.89-3.48] NA NA NA NA 
22.48 
[18.64-26.69] NA 
Iliescu 4.77 
[4.22-5.37] 
2.98 
[2.54-3.46] 132 261 187 
50.57 
[44.34-56.80] 
39.88 
[32.30-47.83] 
53.44 
[47.01-59.79] 
Wang 1.24 [0.87-1.72] 
0.82 
[0.52-1.22] 23 35 3 
65.71 
[47.79-80.87] 
56.52 
[34.49-76.81] 
69.70 
[51.29-84.41] 
Natu  
(Low risk) 
0.73 
[0.20-1.85] NA 2 4 0 
50.00 
[6.76-93.24] NA 
50.00 
[6.76-93.24] 
Pooled 
Results 
1.81 
[1.72-1.90] 
1.63 
[1.54-1.72] 526 1521 254 
32.35 
[22.45-43.12] 
35.56 
[26.27-45.44] 
41.10 
[32.13-50.38] 
 
TP – True positives. FP – False Positives, FN – False Negatives. USS – Ultrasound. NA – Not available. 
Note: The specificity of first trimester ultrasound for major anomaly detection was not calculated due to the small numbers of studies, 
which provided data on false positive diagnoses.  
*Those studies which did not provide data on the number of affected fetuses within their cohorts were not included in the pooled 
estimates of  ‘Prevalence of affected fetuses’ and of ‘Sensitivity of 1st trimester USS for detection of affected fetuses’. 
**Those studies which only performed one antenatal USS on fetuses during pregnancy were not included in the pooled estimate of 
‘Antenatal anomalies diagnosed during the 1st trimester’. 
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Table 5 – Summary of results from studies assessing the sensitivity of first trimester ultrasound for the detection of all types of 
fetal structural abnormalities in high risk pregnancies (Subgroup 3). 
 
Group  
 
Number of 
Anomalies 
Present 
Within Study 
per 100 
fetuses  
[95% C.I.] 
 
 
Prevalence of 
Affected 
Fetuses 
within Study 
Population* 
(%)  
[95% C.I.] 
Anomalies 
Detected 
in 1st 
Trimester 
(TP) 
Total 
Anomalies 
Present in 
Study 
(TP+FN) 
False 
Positives 
Detected 
during 1st 
Trimester 
USS 
(FP) 
Sensitivity of 1st 
Trimester USS 
for Anomaly 
Detection (%) 
[95% C.I.] 
Sensitivity of 1st 
Trimester USS 
for Detection of 
Affected Fetuses* 
(%) [95% C.I.] 
 
 
Antenatal 
Diagnoses Made 
with 1st 
Trimester USS 
(%) 
 
Pandya  6.37 [4.50-8.71] 
5.66 
[3.91-7.90] 12 36 NA 
33.33 
[18.56-50.97] 
34.38 
[18.57-53.19] 
35.29 
[19.75-53.51] 
Bilardo  
(High risk) 
19.15 
[9.15-33.26] 
14.89 
[6.2-28.31] 2 9 NA 
22.22 
[2.81-60.01] 
28.57 
[3.67-70.96] 
33.33 
[4.33-77.72] 
Den Hollander 26.73 [18.41-36.46] 
10.89 
[5.56-18.65] 20 27 0 
74.07 
[53.72-88.89] 
81.82 
[48.22-97.72] 
83.33 
[62.62-95.26] 
Chen 3.42 [2.59-4.43] 
1.55 
[1.01-2.29] 32 55 5 
58.18 
[44.11-71.35] 
52.00 
[31.31-72.20] 
64.00 
[49.19-7.08] 
Bronshtein 94.87 [82.68-99.37] 
33.33 
[19.09-50.22] 36 37 2 
97.30 
[85.84-99.93] 
100.00 
[75.29-100.00] 
97.30 
[85.84-99.93] 
Natu 
(High Risk) 
4.44 
[2.80-6.64] NA 14 22 0 
63.64 
[40.66-82.80] NA 
63.64 
[40.66-82.80] 
Pooled Results 6.55 [5.66-7.52] 
3.75 
[3.02-4.60] 116 186 7 
61.18 
[37.71-82.19] 
62.42 
[33.40-87.24] 
66.29 
[43.47-85.69] 
Abbreviations: TP – True positives. FP – False Positives, FN – False Negatives. USS – Ultrasound. NA – Not available. 
*Those studies which did not provide data on the number of affected fetuses within their cohorts were not included in the pooled 
estimates of  ‘Prevalence of affected fetuses’ and of ‘Sensitivity of 1st trimester USS for detection of affected fetuses’. 
 
This article is protected by copyright. All rights reserved.
Ac
c
e
p
t
e
d
 
A
r
t
i
c
l
e
Table 6 – Summary of Results from Meta-Analysis 
Subgroup Population/Anomaly Type 
Outcomes 
 
Number of 
Anomalies 
Present Within 
Study per 100 
fetuses [95% C.I.] 
 
Sensitivity of 1st 
Trimester USS 
for Anomaly 
Detection (%) 
[95% C.I.] 
 
Antenatal 
Diagnoses Made 
with 1st 
Trimester USS 
(%) [95% C.I.] 
 
1 Major Anomalies in a Low Risk/Unselected Population 
1.01 
[0.95-1.07] 
46.10 
[36.88-55.46] 
53.47 
[43.42-63.37] 
2 All Types of Anomalies in a Low Risk/Unselected Population 
1.81 
[1.72-1.90] 
32.35 
[22.45-43.12] 
41.10 
[32.13-50.38] 
3 All Types of Anomalies in a High Risk Population 
6.55 
[5.66-7.52] 
61.18 
[37.71-82.19] 
66.29 
[43.47-85.69] 
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Supplement A: Search strategy for systematic review of diagnostic accuracy of first trimester two-dimensional ultrasound for fetal 
structural abnormalities. 
 
The search was conducted using Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations and Ovid 
MEDLINE(R)[OvidSP](1946-present), Embase [OvidSP](1974-2014 July 17), Cochrane Central Register of Controlled Trials 
[Cochrane Library, Wiley](Issue 6 of 12, 2014), Database of Abstracts of Reviews of Effects [Cochrane Library, Wiley](Issue 2 of 4, 
2014), Science Citation Index-Expanded [Web of Science Core Collection, Thomson Reuters](1945-present). 
 
Search 
# 
Searches Conducted Results 
1 Ultrasonography, Prenatal/ 24571 
2 Prenatal diagnosis/ and exp ultrasonography/ 6667 
3 (ultrasound* or ultra-sound or ultrasonogra* or ultra-sonogra* or 
sonogra* or echocardiogra*).ti,ab. 
350062 
4 ((fetal or foetal or fetus or foetus or prenat* or pre-nat* or prepart* 
or pre-part*) adj3 (screen* or scan* or structural assessment* or 
structural survey*)).ti,ab. 
4946 
5 1 or 2 or 3 or 4 363227 
6 Pregnancy Trimester, First/ 13090 
7 (1st trimester or first trimester).ti,ab. 17031 
8 (early pregnan* or early gestation*).ti,ab. 14840 
9 (10 week? or 11 week? or 12 week? or 13 week? or 14 
week?).ti,ab. 
95426 
10 (10week? or 11week? or 12week? or 13week? or 14week?).ti,ab. 535 
11 ((ten*2 or eleven*2 or twel*3 or thirteen*2 or fourteen*2) adj 
week?).ti,ab. 
5950 
12 6 or 7 or 8 or 9 or 10 or 11 131973 
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13 exp *Congenital Abnormalities/ 368002 
14 (congenital* adj2 (defect? or malformation? or abnormalit* or 
anomal*)).ti,ab. 
46663 
15 ((fetal or foetal or fetus or foetus) adj2 (defect? or malformation? 
or abnormalit* or anomal*)).ti,ab. 
7081 
16 (structural adj2 (defect? or malformation? or abnormalit* or 
anomal*)).ti,ab. 
12112 
17 ((non-chromosomal or nonchromosomal) adj2 (defect? or 
malformation? or abnormalit* or anomal*)).ti,ab. 
80 
18 13 or 14 or 15 or 16 or 17 405021 
19 5 and 12 and 18 2386 
20 ((fetal or foetal or fetus or foetus) adj (anatomy or defect? or 
malformation? or abnormalit* or anomal*) adj5 (ultrasound* or 
ultra-sound or ultrasonogra* or ultra-sonogra* or sonogra* or 
echocardiogra* or scan* or screen* or survey* or 
assessment?)).ti,ab. 
891 
21 exp Congenital Abnormalities/us [Ultrasonography] 16703 
22 20 or 21 17312 
23 12 and 22 1383 
24 ((early pregnan* or early gestation* or 1st trimester or first 
trimester) adj3 (ultrasound* or ultra-sound or ultrasonogra* or 
ultra-sonogra* or sonogra* or echocardiogra* or scan* or screen* 
or survey* or assessment?)).ti,ab. 
2264 
25 ((10 week? or 11 week? or 12 week? or 13 week? or 14 week?) 
adj3 (ultrasound* or ultra-sound or ultrasonogra* or ultra-sonogra* 
or sonogra* or echocardiogra* or scan* or screen* or survey* or 
assessment?)).ti,ab. 
1150 
26 ((10week? or 11week? or 12week? or 13week? or 14week?) adj3 
(ultrasound* or ultra-sound or ultrasonogra* or ultra-sonogra* or 
sonogra* or echocardiogra* or scan* or screen* or survey* or 
10 
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assessment?)).ti,ab. 
27 ((ten*2 or eleven*2 or twel*3 or thirteen*2 or fourteen*2) adj 
week? adj3 (ultrasound* or ultra-sound or ultrasonogra* or ultra-
sonogra* or sonogra* or echocardiogra* or scan* or screen* or 
survey* or assessment?)).ti,ab. 
34 
28 24 or 25 or 26 or 27 3332 
29 18 and 28 1113 
30 19 or 23 or 29 2744 
31 limit 30 to "reviews (maximizes specificity)" 44 
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Supplement B - QUADAS -2 Assessment Tool: 
 
Defining the review question: 
 
1. What is the sensitivity of first trimester ultrasound for structural fetal malformations? Is it a sensitive enough tool for use in daily 
clinical practice? 
 
2. What factors might impact detection rates? 
 
-Patient selection: pregnant women with gestational age prior to 14 weeks, mothers with all levels of risk and with either singleton or 
multiple pregnancies were included 
 
-Index Test: Transvaginal and/or Transabdominal 2D Ultrasound prior to 14 weeks gestational age. 
 
-Reference Standard: Postnatal examination of fetus for structural abnormalities, or postmortem of fetus for structural abnormalities.  
 
-Target condition: all types of congenital fetal structural anomalies (lethal, severe, moderate, and minor as defined by the RCOG). 
 
Domain 1:  Patient Selection 
 
A. Risk of Bias : Could the selection of patients have introduced bias?  
                                                                                                            
LOW/HIGH/UNCLEAR 
 
i. Was a consecutive or random sample of patients enrolled?           YES/NO/UNCLEAR 
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ii. Did the study avoid inappropriate exclusions?    YES/NO/UNCLEAR 
 
B. Applicability 
i. Are there concerns that the included patients and setting do not match the review question (i.e. severity of the target condition, 
demographic features, presence of co-morbidity, setting)?                                                                 LOW/HIGH/UNCLEAR 
 
 
 
 
Domain 2: Index Test 
 
A. Risk of Bias - Could the conduct or interpretation of the index test have introduced bias?                        
LOW/HIGH/UNCLEAR 
i. Were sonographers blinded to the history (risk profile) of the patients?     
                                                                                                             YES/NO/UNCLEAR  
ii. Were all major anatomical organs included in the index test examination?    
 YES/NO/UNCLEAR 
iii. Did the study adequately and clearly specify what types of abnormalities were to be assessed by 1st term USS?            
    YES/NO/UNCLEAR 
 
B. Applicability 
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i. Are there concerns that the index test, its conduct, or interpretation differ from the review question?      
        LOW/HIGH/UNCLEAR  
 
Domain 3: Reference Standard 
 
A. Risk of Bias – Could the reference standard, its conduct, or its interpretation have introduced bias?                                                                 
LOW/HIGH/UNCLEAR 
i. Was an appropriate reference standard used to correctly classify the target condition?        
       YES/NO/UNCLEAR 
B. Applicability 
i. Are there concerns that the target condition as defined by the reference standard does not match the question?     
        LOW/HIGH/UNCLEAR 
 
Domain 4: Flow and Timing 
 
A. Risk of Bias – Could the patient flow have introduced bias? 
       LOW/HIGH/UNCLEAR 
 
i. Was a reference standard performed for all appropriate patients enrolled in the study? (including post-mortems for still-births/TOPs 
in those with diagnosed malformations)                                                   
YES/NO/UNCLEAR 
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ii. Were all patients enrolled in the study (and who had complete follow-up data) included in the analysis?    
   YES/NO/UNCLEAR 
 
iii. Were all measures of 1st trimester ultrasound detection accuracy (eg. TP, FP, TN, FN) reported?                      
               YES/NO/UNCLEAR 
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Supplement C: Table of studies included and details regarding which subgroup analysis they contributed to: 
Chen et al. (2008)(19), Abu-Rustum et al. 
(2010)(20), Hildebrand et al. (2010)(21), 
Jakobsen et al. (2011)(22) and Grande et al. 
(2012)(23) 
Data on fetuses with major 
abnormalities and on those with a wider 
range of anomalies were presented, 
allowing these studies to be analyzed as 
part of both subgroups 1 and 2.  
Saltvedt et al. (2006)(24) Reported on the detection of all types 
of abnormalities. However, they only 
provided a breakdown of major 
abnormalities and as such was 
evaluated as part of subgroup 1. 
Chen et al. (2008)(19) In this prospective randomized control 
trial, which compared the first term 
detection rates between a control group 
(randomized to receive only a nuchal 
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scan at 10-14+6 weeks) and a study 
cohort (randomized to receive a nuchal 
scan at 10-14+6 weeks in addition to a 
detailed anomaly scan at 12-14+6 
weeks). We collated data on the two 
population cohorts of this study 
separately, as one group had a detailed 
first trimester anomaly scan with the 
use of an anatomical checklist, whereas 
the other did not. 
Bilardo et al. (1998)(25)  Provided data on both a cohort of 
euploid fetuses with normal nuchal 
scans (low risk) and a cohort of euploid 
fetuses with raised nuchal translucency 
(high risk), which were analyzed 
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separately in subgroups 2 and 3 
respectively. 
Natu et al.(2014)(26)  Assessed unspecified types of 
anomalies in both low risk and high 
risk populations and therefore data 
from this study was analyzed in both 
subgroups 2 and 3.   
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